1. Home
  2. PLRX vs CCNE Comparison

PLRX vs CCNE Comparison

Compare PLRX & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • CCNE
  • Stock Information
  • Founded
  • PLRX 2015
  • CCNE 1865
  • Country
  • PLRX United States
  • CCNE United States
  • Employees
  • PLRX N/A
  • CCNE N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • CCNE Major Banks
  • Sector
  • PLRX Health Care
  • CCNE Finance
  • Exchange
  • PLRX Nasdaq
  • CCNE Nasdaq
  • Market Cap
  • PLRX 682.2M
  • CCNE 595.8M
  • IPO Year
  • PLRX 2020
  • CCNE N/A
  • Fundamental
  • Price
  • PLRX $10.92
  • CCNE $24.85
  • Analyst Decision
  • PLRX Strong Buy
  • CCNE Hold
  • Analyst Count
  • PLRX 7
  • CCNE 1
  • Target Price
  • PLRX $40.50
  • CCNE $28.00
  • AVG Volume (30 Days)
  • PLRX 509.0K
  • CCNE 78.9K
  • Earning Date
  • PLRX 02-26-2025
  • CCNE 01-28-2025
  • Dividend Yield
  • PLRX N/A
  • CCNE 2.87%
  • EPS Growth
  • PLRX N/A
  • CCNE N/A
  • EPS
  • PLRX N/A
  • CCNE 2.33
  • Revenue
  • PLRX N/A
  • CCNE $216,515,000.00
  • Revenue This Year
  • PLRX N/A
  • CCNE N/A
  • Revenue Next Year
  • PLRX N/A
  • CCNE $20.12
  • P/E Ratio
  • PLRX N/A
  • CCNE $10.66
  • Revenue Growth
  • PLRX N/A
  • CCNE N/A
  • 52 Week Low
  • PLRX $10.22
  • CCNE $17.74
  • 52 Week High
  • PLRX $18.92
  • CCNE $29.29
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 35.54
  • CCNE 48.27
  • Support Level
  • PLRX $10.94
  • CCNE $22.40
  • Resistance Level
  • PLRX $12.70
  • CCNE $25.04
  • Average True Range (ATR)
  • PLRX 0.72
  • CCNE 0.69
  • MACD
  • PLRX -0.19
  • CCNE 0.16
  • Stochastic Oscillator
  • PLRX 4.78
  • CCNE 86.88

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. In addition, the corporation provides wealth and asset management services, retirement plans and other employee benefit plans.

Share on Social Networks: